Below 3 companies have released their full year results lately and a snippet on the same has been provided herein:
Beacon Lighting Group Ltd (ASX:BLX), a specialist lighting retailer, saw its stock trading around $1.56 with a daily price change of $0.01 or 0.645%, as at August 17, 2018. The stock has seen a performance change of 20.16% over the past 12 months. The company recorded FY18 sales result with an increase of 9.7% at $236.0 million. The companyâs gross profit margins increased by 2.3% of sales at 65.7% and recorded group EBITDA result with an increase of 20.1% at $33.2m. The recorded group NPAT witnessed an increase of 17.7% resulting at $19.6 million. The initial few weeks of FY19, have however, not revealed significant sales growth.
GWA Group Ltd (ASX:GWA) is an industrials sector group known for providing various building fixtures as well as fittings at residential and commercial properties. The companyâs stock traded around $3.61 with a daily price change of $0.03 or 0.838%, as at August 17, 2018. The stock has seen a performance change of 14.01% over the past 12 months. GWA has established strong platform for future growth and delivered solid full year result, with EBIT of $84.4 million, which is up 4.7%. The companyâs NPAT is up to $56.0 million, i.e., a rise of 4.3% and full year dividend of 18.0 cents per share fully franked has been up by 9.1%. The groupâs revenue increased by 2.5 percent. The group has a decent pipeline of building work and has done well in the Bathroom and Kitchen business segment.
[optin-monster-shortcode id="wxhmli4jjedneglg1trq"]IPH Limited (ASX:IPH) is the industrial sector company that operates in intellectual property services. The companyâs stock traded around $5.560 with a daily price change of $0.110 or 2.018%, as at August 17, 2018. The stock has seen a performance change of 20.04% over the past 12 months. With regards to merger on FAKC/ Cullensand Spruson & Ferguson, the group updated the market that these businesses have been integrated effectively now and about $1 million of synergies have been slated in FY19. The full year FY18 revenue is up by 21.5% at $226 million and the EBITDA is up by 2.1% at $70.1 million. The dividend is up by 2.3 percent which is at 22.5 cents per share. However, NPAT is down by 5.2% compared to the previous year at $40.7 million. The healthy cashflow position is supporting the dividend payout (which is 91% of FY18 cash NPAT). The group has seen a recovery in the patent market in Australia and the filings have been up by 5.2% for second half over the previous corresponding period.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a companyâs prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkineâs team of analysts bought you handpicked report for âTop 25 Dividend Stocks For 2018.â
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.